(Part 6 of 9) David Hinton, Ph.D., spoke at the Scientific Writer's Seminar, a workshop presented on September 17, 2008 at CIRM headquarters in San Francisco. Hinton has a CIRM grant to study the therapeutic potential of retinal pigment epithelial cell lines derived from human embryonic stem cells for retinal degeneration
See the rest here:
Stem Cell Based Therapies for Blindness: David Hinton - CIRM Science Writer's Seminar - Video
Recommendation and review posted by G. Smith